Posted on 24 May 2018

Participation of VIVEbiotech in the ASGCT Annual Meeting

VIVEbiotech participated in the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting that took place in Chicago on May 16, 17, 18 and 19, a congress in which more than 2,500 professionals from the sector gathered.

This meeting is the most important in the field of gene and cell therapy worldwide.

Natalia Elizalde, the Director of Business Development, and Juan Carlos Ramírez, the Chief Science-Technology Office of VIVEbiotech, were present at the congress. VIVEbiotech participated in this 21st edition with a stand, and giving a talk entitled “Lentiviral Vectors: Safety and Manufacturing Related Aspects“.

This is one of the annual events in which VIVEbiotech will be present, thus making known its important contribution to the sector, and strengthening its growing network in the field of advanced therapies.